Management of Respiratory Distress in COVID-19 Patients

The management of respiratory distress in patients infected with SARS-CoV-2 encompasses a spectrum from minimal supplementary oxygen to advanced mechanical ventilation and extracorporeal support. Early identification of acute respiratory distress syndrome (ARDS) and differentiation of phenotypes—such as hyperinflammatory versus hypoinflammatory—guide therapeutic decisions. Strategies focus on maintaining adequate oxygenation while minimising ventilator-induced lung injury through lung protective ventilation, appropriate positive end-expiratory pressure (PEEP) titration and prone positioning. Non-invasive modalities, including high-flow nasal oxygen (HFNO) and non-invasive ventilation, have been applied to reduce intubation rates, though close monitoring is essential to avoid delayed invasive support. Recognition of a significant vascular component, characterised by microthrombi and ventilation–perfusion mismatch, has prompted integration of anticoagulation protocols and consideration of pulmonary perfusion modulation. Adjunctive measures—such as corticosteroids, neuromuscular blockade, and sedation regimens—are calibrated to individual patient physiology. Emerging approaches involve biomarker-driven phenotyping and dynamic re-classification during the early course of critical illness to refine prognostic estimation and personalise interventions.

Research from Nature Portfolio

A mathematical modelling study has elucidated how early COVID-19 hypoxaemia may arise from a combination of pulmonary vascular defects rather than alveolar injury alone. The model demonstrates that extensive microembolic occlusion, ventilation–perfusion mismatch in ostensibly healthy lung regions and heterogeneous perfusion redistribution can account for severe oxygen desaturation despite preserved lung mechanics. These insights underscore the importance of targeting the pulmonary microcirculation through anticoagulant strategies and perfusion-guided therapies, complementing conventional ventilatory support.

Management of Respiratory Distress in COVID-19 Patients publication trend

The graph below shows the total number of articles in management of respiratory distress in covid-19 patients across all publications each year (not limited to Nature Index journals).

Technical terms

Acute respiratory distress syndrome (ARDS): Severe inflammatory lung condition marked by hypoxaemia and reduced compliance due to non-cardiogenic pulmonary oedema.

Positive end-expiratory pressure (PEEP): Baseline airway pressure applied during mechanical ventilation to prevent alveolar collapse and improve oxygenation.

Ventilation–perfusion (V/Q) mismatch: Imbalance between alveolar ventilation and pulmonary blood flow leading to impaired gas exchange.

Compliance (respiratory system compliance): Measure of lung distensibility, defined as volume change per unit pressure change during ventilation.

High-flow nasal oxygen (HFNO): Oxygen delivery system providing warmed, humidified gas at high flow rates to support respiratory drive and oxygenation.

Prone positioning: Placement of a patient face down to redistribute perfusion and ventilation, improving oxygenation in ARDS.

Nucleated red blood cells (nRBC): Immature erythroid precursors in peripheral blood, indicative of bone marrow stress and associated with worse outcomes.

Hypoxic pulmonary vasoconstriction: Physiological constriction of pulmonary arterioles in poorly ventilated regions to optimise V/Q matching.

References

1. Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort. Critical Care (2024).
2. Epidemiology, ventilation management and outcomes of COVID–19 ARDS patients versus patients with ARDS due to pneumonia in the Pre–COVID era. Respiratory Research (2024).
3. Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method. Critical Care (2021).
4. Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia. Nature Communications (2020).